Abstract Studies have suggested a possible role for Blastocystis hominis and Dientamoeba fragilis in the etiology of irritable bowel syndrome (IBS). We studied the prevalence of B. hominis and D. fragilis in patients with IBS-diarrhea (IBS-D). Three hundred and thirty patients were enrolled, 171 (52%) with IBS-D and 159 (48%) were controls, respectively. Stool microscopy, culture, and polymerase chain reaction (PCR) for B. hominis and D. fragilis were done. B. hominis was positive by stool microscopy in 49% (83/171) of IBS compared to 24% (27/159) in control (p<0.001). B. hominis culture was positive in 53% (90/171) in IBS compared to 16% (25/159) in control (p<0.001). B. hominis PCR was positive in 44% (75/171) in IBS compared to 21% (33/159) in control (p< 0.001). D. fragilis microscopy was positive in 3.5% (6/171) in IBS-D compared to 0.6% (1/159) in control (p=0.123). D. fragilis culture was positive in 4% (7/171) in IBS compared to 1.3% (2/159) in control (p=0.176). D. fragilis PCR was positive in 4% (6/171) in IBS-D compared to 0% (0/159) in control (p=0.030). B. hominis is common, while D. fragilis was less prevalent in our patients with IBS-D. B. hominis and D. fragilis culture had a better yield compared to stool microscopy and PCR.
Introduction
Parasitic infections afflict a wide range of populations in both urban and rural areas throughout the world. The direct impact of protozoan parasites on human is considerable in the third world countries with poor sanitation and quality of drinking water (Zonta et al. 2010) . Parasitic infections such as Blastocystis hominis and Dientamoeba fragilis are associated with abdominal pain, bloating, and alteration of bowel habits resembling irritable bowel syndrome (IBS; Yakoob et al. 2004; Johnson et al. 2004 ). However, a diagnosis of IBS is based on ROME III criteria independently of specific stool collection and testing methods recommended for detection of parasites (Drossman 2006) . Also, the methods commonly used to diagnose parasitic infections have a poor yield, and hence, these infections are never diagnosed. The prevalence of these parasites is highest in areas of poor sanitation and drinking water treatment as they are transmitted by fecal-oral route.
A significantly increased level of IgG2 levels against B. hominis was found in IBS patients compared with asymptomatic controls, indicating that the predominant response in these patients may be directed to carbohydrate antigens (Hussain et al. 1997) . A number of studies have incriminated D. fragilis as a cause of IBS, allergic colitis, and diarrhea in human immunodeficiency virus patients (Johnson et al. 2004) . In a recent study, a high prevalence of D. fragilis was reported in fecal samples collected from patients attending complementary medicine practitioners in the British Isles (Windsor et al. 2002) . Approximately 25% of these stated intestinal symptoms, ranging from acute gastroenteritis to chronic intestinal symptoms, while similar in proportion did not report having intestinal symptoms. It is also noteworthy that over half of the D. fragilis positive samples were found in combination with B. hominis as previously observed (Stensvold et al. 2007; Schuster and Jackson 2009; Stark et al. 2005; Norberg et al. 2003) . B. hominis is a common human intestinal parasite that is commonly found in stool on examination. It can be easily demonstrated by light microscopy, culture, and polymerase chain reaction (PCR) examination of stool samples (Norberg et al. 2003; Zaman and Khan 1994) . The pathogenic role of B. hominis is still controversial as it is frequently found not only in individuals with enteric symptoms but also in apparently healthy and asymptomatic subjects (Silberman et al. 1996) . It is thought that genotypic difference exists between the asymptomatic and symptomatic B. hominis isolates (Stensvold et al. 2006; Yoshikawa et al. 2000) . The aim of this study was to determine the prevalence of B. hominis and D. fragilis in patients with symptoms of IBS-D and compared them with healthy immunocompetent controls.
Materials and methods

Patient
A total of 330 stool samples were examined that were obtained from patients fulfilling Rome III criteria of IBS-D in 171 (52%) and 159 (48%) controls who attended the gastroenterology outpatient clinic at the Aga Khan University, Karachi between January 2008 and December 2009, respectively (Drossman 2006 ). The mean age of patients with IBS-D was 40±15, age range 16-83 years, and male: female ratio of 117:54. In control group, 159 (48%) were healthy volunteers with mean age 42±14. These patients underwent thorough history, physical examination, complete blood count, serum creatinine, electrolytes, and stool microscopy, culture, and PCR for B. hominis and D. fragilis. These patients had intact immunity. The study was approved by institutional ethics review committee.
All the stool specimens were processed by stool microscopy for B. hominis and D. fragilis. Stool culture was done for B. hominis and D. fragilis. DNA was extracted from the unfixed stool specimen, and it was used for PCR for B. hominis and D. fragilis. A note was made of the presence of other parasites such as Giardia lamblia, Entamoeba species, and Cryptosporidium, and these patients, ten in number, were excluded while no patient demonstrated Enterobius vermicularis. In previous study, D. fragilis mono-nucleated or bi-nucleated forms have been documented in the lumen of E. vermicularis (Johnson et al. 2004) . A microbiological investigation was also performed to detect Salmonella spp., Campylobacter jejuni, Clostridium difficile, and Vibrio cholerae. However, a viral screen was not carried out on stool specimens in view of restriction of cost.
Microscopy of fecal smear
Fecal sample microscopy for demonstrating B. hominis was done as described before (Zaman and Khan 1994) ; approximately 2 mg of feces was emulsified on a glass slide in one drop of physiologic saline and covered with a cover slip. A similar preparation was made on another slide using Lugol's iodine. These preparations were examined under both the low power (×10) and high dry (×40) objectives. Specimen smear was fixed in sodium acetate/acetic acid/formalin (SAF) and then stained with modified trichrome stain to look for D. fragilis (Johnson et al. 2004 ).
Culture
Jones medium without starch was used for culturing B. hominis as described before (Zaman and Khan 1994) . The cultures were incubated at 37°C and examined after 48 h. If no B. hominis were seen up to further 2 days, they were regarded as negative. The sediment was examined under both the low power (×10) and high dry (×40) objectives. D. fragilis culture was done in Robinson's medium as previously described (Windsor et al. 2003) .
Extraction of genomic DNA Stool DNA was extracted by using Stool DNA Extraction kit (Qiagen) according to the manufacturer's protocol. Extracted DNA was stored at −20°C until PCR was carried out for B. hominis and D. fragilis
PCR
The primers used were previously described ( Table 1) . The primer pair SR1F and SR1R was used to amplify a conserved region of the B. hominis small subunit (SSU) rRNA, while primer TRD3 and TRD5 design was based on the sequence of the of SSU rRNA gene of D. fragilis (Silberman et al. 1996; Yoshikawa et al. 2000 ; Table 1 ). The PCR reaction volume was 25 μl that comprised of 2.5 μl of 10× PCR buffer (Promega), 2.0 μl of 25 mM MgCl 2 (Promega), 0.4 μl of deoxyribo-nucleotide triphosphate mix (10 mM each dNTP, Promega), 0.5 μl (5 IU/μl) of Taq polymerase (Promega), 1 μl (0.25 μM) primers (IDT), and 2.0 μl of template DNA. The PCR products and molecular markers were electrophoresed in 2% agarose gel with Tris-acetate-EDTA electrophoresis buffer. The size markers were 100 bp ladder (Promega, USA). The PCR amplification for each primer pair was repeated at least thrice. Bands were visualized by the imaging system (Gel Doc 2000, Gel Documentation System, Bio Rad, UK) after being stained with ethidium bromide.
Statistical method
Results are expressed as mean±standard deviation for continuous variables (e.g., age) and number (percentage) for categorical data (e.g., gender, stool culture, and diarrhea). Univariate analysis was performed by using the independent sample t test, Pearson Chi-square test, and Fisher exact test where appropriate. A p value of <0.05 was considered as statistically significant. All p values were two sided. Statistical interpretation of data was performed by using the computerized software program SPSS version 16.0.
Results
The age and sex of the patients were not related to the positivity of D. fragilis and B. hominis when culture was used as the diagnostic test for D. fragilis and B. hominis. One hundred ninety-three (59%) had diarrhea, and 71 (52%) had abdominal pain.
Distribution and diagnostic yield of various tests for B. hominis B. hominis was positive by microscopy in 33% (110/330), culture in 35% (115/330), and PCR in 33% (108/330; Table 2 ). Microscopy for B. hominis was positive in 76% (83/110) in patients fulfilling the criteria of IBS compared to 24% (27/110) in control (p<0.001; Table 3 ). Culture for B. hominis was positive in 78% (90/115) in IBS compared to 22% (25/115) in control (p<0.001). PCR for B. hominis was positive in 69% (75/108) in IBS compared to 31% (33/ 108) in control (p<0.001; Table 3 ).
Distribution and diagnostic yield of various tests for D. fragilis D. fragilis was positive by microscopy in 2% (7/330), culture in 3% (11/330), and PCR in 2% (6/330), respectively (Fig 1; Table 2 ). Microscopy for D. fragilis was positive in 86% (6/7) in IBS compared to 14% (1/7) in control (p=0.123; Table 3 ). Culture for D. fragilis was positive in 64% (7/11) in IBS compared to 36% (4/11) in control (p=0.425; Table 3 ). PCR for D. fragilis was positive in 86% (6/6) in IBS compared to none in control (p=0.030; Table 3 ).
Coinfection with B. hominis and D. fragilis in different groups
Microscopy was positive for both B. hominis and D. fragilis in 3% (5/171) with IBS compared to zero (0/159) in control (p=0.061; Table 2 ). Culture for both B. hominis and D. fragilis was positive in 2.3% (4/171) with IBS compared to zero (0/159) in control (p=0.123; Table 3 ). PCR was positive for both B. hominis and D. fragilis in 3% (5/171) with IBS compared to zero (0/159) in control (p=0.061; Table 3 ).
Comparison of culture for B. hominis and D. fragilis with other test
In patients with IBS, B. hominis culture was positive in 90, while microscopy for B. hominis was positive in 82% (74/ 90; p<0.001) and PCR in 76% (68/90; p<0.001). In IBS patients, D. fragilis was positive in seven (4%) with culture, (2000) b Silberman et al. (1996) while microscopy for D. fragilis was positive in 57% (4/7; p<0.001), and PCR for D. fragilis was not positive in any patients 0/7 (p=1).
Discussion
This study showed B. hominis was significantly positive in IBS while D. fragilis was positive in only 4%. In patients with IBS, B. hominis culture was significantly positive compared to microscopy and PCR for B. hominis. Similarly, culture of D. fragilis had a better yield compared to microscopy with modified trichrome staining and PCR. Coinfection with both B. hominis and D. fragilis in IBS patients was documented in 3% with culture and 2.3% by microscopy. B. hominis and D. fragilis infections did not show any age and gender distribution. However, one third of the D. fragilis infections were in patients who were in their twenties. None of the patients with D. fragilis demonstrated concomitant infection with E. vermicularis. The implications of this study are that B. hominis are found with a higher frequency in our IBS patients compared to D. fragilis. The coinfection of B. hominis and D. fragilis was seen in only IBS group and none in the fecal samples from control group comprising of healthy individuals without gastrointestinal symptoms. This study has shown that D. fragilis was associated with IBS-like symptoms in our patients, though it has a low prevalence. It is still possible that we were not able to document all the D. fragilis infections in spite of using three different modalities, i.e., microscopy with modified trichrome staining of fixed stool specimen, culture of stool specimens, and PCR examination of unfixed stool specimens. It is possible that if we examined three fixed and three unfixed stool specimens from each of these patients, the yield might have increased. Also, increasing number of symptomatic patients would have helped. Windsor et al. found D. fragilis culture has the best yield compared to microscopy with modified iron-hematoxylin staining of stool specimen (Windsor et al. 2003 ). An Australian study previously described an association between D. fragilis and IBS with 21 IBS patients diagnosed with concurrent D. fragilis infection (Brody et al. 2002) . In another prospective study, 6,750 fecal samples were examined for D. fragilis. Trophozoites of D. fragilis were detected in 60 (0.9%) patients by permanent staining, using a modified iron-hematoxylin stain that was confirmed by PCR (Stark et al. 2005) .
Chronic symptoms were present in 32% with diarrhea and abdominal pain present in all of these patients (Stark et (100) al. 2005). In the control group comprising of 900 stool samples from patients without gastrointestinal symptoms, no D. fragilis was detected by permanent staining (Stark et al. 2005) . Our results concur with that of Stark et al. (2005) . This is the first report of documentation of D. fragilis in our population. It was found infrequently in our patients with IBS. D. fragilis is a pathogenic organism rather than a commensal, as diarrhea and abdominal pain were the most common symptoms in both acute and chronic infections (Johnson et al. 2004; Stark et al. 2005; Dobell 1940; Windsor and Johnson 1999; Yang and Scholten 1977) . We also did not find any correlation between D. fragilis and E. vermicularis, a proposed vector of transmission for D. fragilis in keeping with previous study (Stark et al. 2005) . The results of this study concur with a previous study that culture of B. hominis has a better yield than that of microscopy (Zaman and Khan 1994) . However, B. hominis culture yield was not significantly different from B. hominis PCR. In recent years, studies have suggested that there are genotypes of B. hominis associated with symptomatic and asymptomatic states (Hussein et al. 2008; Tan 2008; Yan et al. 2006) . Different degrees of pathological changes were present among infected rats by symptomatic subtypes 1, 3, and 4 compared with asymptomatic subtypes, e.g., 2, 3, and 4 (Hussein et al. 2008) . The moderate and severe degree of pathological changes was found only in symptomatic subtypes infected rats, while mild degree was found only in asymptomatic subtypes infected rats (Hussein et al. 2008 ). The intestinal cell permeability was increased in symptomatic subtype 1 compared to symptomatic subtypes, e.g., 3 and 4, infected rats (Hussein et al. 2008) . Minimal effects were found in the asymptomatic and control groups. These results proved that subtype 1 was clinically and statistically highly relevant to the pathogenicity of B. hominis, while subtype 2 was irrelevant (Hussein et al. 2008) . Also, the results suggested the presence of pathogenic and nonpathogenic strains among subtypes 3 and 4 (Hussein et al. 2008) . A study from China also described a possible relationship between subtype 1 and a pathogenic potential of B. hominis (Yan et al. 2006) . Similarly, Blastocystis subtype 3 was described as the most dominant genotype in asymptomatic individual, and subtype 1 determined all of symptomatic patients in studies from Turkey and Pakistan (Eroglu et al. 2009; Yakoob et al. 2010) . D. fragilis prevalence appears to be low in our IBS population.
In conclusion, we demonstrated presentation of B. hominis and D. fragilis infections with symptoms of IBS; however, only a prospective study with a larger sample size is required to confirm this association of D. fragilis with IBS-like symptoms in our population.
